Jennison Associates
HALO icon

Jennison Associates’s Halozyme HALO Stock Holding History

Jennison Associates’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,190
Closed -$582K – 606
2025
Q2 		$582K Buy
11,190
+105
+0.9% +$5.97K ﹤0.01% 534
2025
Q1 		$707K Sell
11,085
-4,206
-28% -$244K ﹤0.01% 513
2024
Q4 		$731K Buy
+15,291
New +$784K ﹤0.01% 525
2023
Q2 		– Sell
-17,131
Closed -$654K – 589
2023
Q1 		$654K Buy
+17,131
New +$804K ﹤0.01% 548
2022
Q2 		– Sell
-29,658
Closed -$1.18M – 654
2022
Q1 		$1.18M Buy
+29,658
New +$1.06M ﹤0.01% 541
2020
Q1 		– Sell
-26,592
Closed -$471K – 655
2019
Q4 		$471K Buy
+26,592
New +$461K ﹤0.01% 595

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jennison Associates's HALO Position: Q3 2025 in Review

Jennison Associates sold out of Halozyme (HALO) in Q3 2025, closing a stake of 11,190 shares — an estimated $582K sold.

Jennison Associates first reported a position in HALO in Q4 2019 and held it in 6 quarters. The position peaked at $1.18M in Q1 2022. 603 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

  • Jennison Associates reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
  • Jennison Associates sold 11,190 Halozyme shares in Q3 2025, an estimated $582K.
  • Jennison Associates first reported a position in Halozyme in Q4 2019 and held it in 6 quarters.
  • Jennison Associates's Halozyme position peaked at $1.18M in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Jennison Associates's 13F filing for Q3 2025, filed 30 Oct 2025.